Invention Grant
- Patent Title: Methods for prognosis prediction for melanoma cancer
-
Application No.: US15391293Application Date: 2016-12-27
-
Publication No.: US10266902B2Publication Date: 2019-04-23
- Inventor: Michael Alan Black , Jonathan Cebon , Parry John Guilford , Thomas John
- Applicant: Michael Alan Black , Jonathan Cebon , Parry John Guilford , Thomas John
- Applicant Address: NZ Dunedin CH Zurich
- Assignee: PACIFIC EDGE LIMITED,LUDWIG INSTITUTE FOR CANCER RESEARCH
- Current Assignee: PACIFIC EDGE LIMITED,LUDWIG INSTITUTE FOR CANCER RESEARCH
- Current Assignee Address: NZ Dunedin CH Zurich
- Agency: Borson Law Group, PC
- Agent D. Benjamin Borson
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; G06F19/00 ; C12Q1/6886 ; G16H50/30
Abstract:
The invention relates to prognostic markers and prognostic signatures, and compositions and methods for determining the prognosis of cancer in a patient, particularly for melanoma. Specifically, the invention relates to the use of genetic and protein markers for the prediction of the risk of progression of a cancer, such as melanoma, based on markers and signatures of markers. In various aspects, the invention provides methods, compositions, kits, and devices based on prognostic cancer markers, specifically melanoma prognostic markers, to aid in the prognosis and treatment of cancer.
Public/Granted literature
- US20170107583A1 Devices and Methods for Prognosis Prediction for Melanoma Cancer Public/Granted day:2017-04-20
Information query
